Table 2.
Program | Reference | INDEL discovery (%) |
Validation studya | Rate (%) | |
---|---|---|---|---|---|
False positive | False negative | ||||
SOAP | Li et al. (27) | NR | NR | PCRb | 90–100b |
MAQ | Li et al. (28) | <2 | 35c | PCRd | 100d |
BWA | Li and Durbin (29) | NR | NR | ND | N/A |
Pindel | Ye et al. (30) | 2 | 20–31.4 | ND | N/A |
Bowtie | Langmead et al. (31) | NR | NR | ND | N/A |
BFAST | Homer et al. (32) | <3 | 10–20 | ND | N/A |
NR, not reported; ND, not done; N/A, not applicable.
aDefined as a study examining a randomly selected set of INDEL variants predicted in real humans and then measuring the confirmation rate of the predicted variants using an assay such as PCR-RFLP, PCR sequencing, microarray genotyping or similar assay.
bFrom the Han Chinese genome sequencing project (3).
cAt 20X coverage.
dFrom the Korean Genome Project (7), nine coding INDELs were examined.